Literature DB >> 33679786

TNFRSF13B Diversification Fueled by B Cell Responses to Environmental Challenges-A Hypothesis.

Marilia Cascalho1, Jeffrey L Platt1.   

Abstract

B cell differentiation and memory are controlled by the transmembrane activator and CAML interactor (TACI), a receptor encoded by TNFRSF13B. TNFRSF13B mutations are frequently found in common variable immunodeficiency (CVID) and in IgA -deficiency; yet, ~98% of those with mutant TNFRSF13B are healthy. Indeed, TNFRSF13B is among the 5% most polymorphic genes in man. Other mammals evidence polymorphism at comparable loci. We hypothesize that TNFRSF13B diversity might promote rather than detract from well-being by controlling key elements of innate immunity. We shall discuss how extraordinary diversity of TNFRSF13B could have evolved and persisted across diverse species of mammals by controlling innate and adaptive B cell responses in apparently paradoxical ways.
Copyright © 2021 Cascalho and Platt.

Entities:  

Keywords:  B-lymphocyte; T cell-dependent antibody response; T cell-independent antibody responses; TNFRSF13B; antibodies

Year:  2021        PMID: 33679786      PMCID: PMC7925820          DOI: 10.3389/fimmu.2021.634544

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  68 in total

Review 1.  Structural insights into antibody-mediated mucosal immunity.

Authors:  A E Hamburger; P J Bjorkman; A B Herr
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

2.  Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab')2: a possible implication for mucosal defense.

Authors:  P Crottet; B Corthésy
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

Review 3.  IgA Function in Relation to the Intestinal Microbiota.

Authors:  Andrew J Macpherson; Bahtiyar Yilmaz; Julien P Limenitakis; Stephanie C Ganal-Vonarburg
Journal:  Annu Rev Immunol       Date:  2018-01-26       Impact factor: 28.527

4.  Selective activation of TACI by syndecan-2.

Authors:  Daniela Bischof; Sherine F Elsawa; George Mantchev; Juhan Yoon; Grace E Michels; Allan Nilson; Shari L Sutor; Jeffrey L Platt; Stephen M Ansell; Gotz von Bulow; Richard J Bram
Journal:  Blood       Date:  2005-12-15       Impact factor: 22.113

5.  IgA deficiency: clinical correlates and responses to pneumococcal vaccine.

Authors:  Eki Edwards; Samiya Razvi; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2004-04       Impact factor: 3.969

6.  Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems.

Authors:  Louise Royle; Anja Roos; David J Harvey; Mark R Wormald; Daniëlle van Gijlswijk-Janssen; El-Rashdy M Redwan; Ian A Wilson; Mohamed R Daha; Raymond A Dwek; Pauline M Rudd
Journal:  J Biol Chem       Date:  2003-03-10       Impact factor: 5.157

7.  TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation.

Authors:  X Z Xia; J Treanor; G Senaldi; S D Khare; T Boone; M Kelley; L E Theill; A Colombero; I Solovyev; F Lee; S McCabe; R Elliott; K Miner; N Hawkins; J Guo; M Stolina; G Yu; J Wang; J Delaney; S Y Meng; W J Boyle; H Hsu
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

8.  mTOR intersects antibody-inducing signals from TACI in marginal zone B cells.

Authors:  Jordi Sintes; Maurizio Gentile; Shuling Zhang; Yolanda Garcia-Carmona; Giuliana Magri; Linda Cassis; Daniel Segura-Garzón; Alessandra Ciociola; Emilie K Grasset; Sabrina Bascones; Laura Comerma; Marc Pybus; David Lligé; Irene Puga; Cindy Gutzeit; Bing He; Wendy DuBois; Marta Crespo; Julio Pascual; Anna Mensa; Juan Ignacio Aróstegui; Manel Juan; Jordi Yagüe; Sergi Serrano; Josep Lloreta; Eric Meffre; Michael Hahne; Charlotte Cunningham-Rundles; Beverly A Mock; Andrea Cerutti
Journal:  Nat Commun       Date:  2017-11-13       Impact factor: 14.919

9.  IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM.

Authors:  Jason R Catanzaro; Juliet D Strauss; Agata Bielecka; Anthony F Porto; Francis M Lobo; Andrea Urban; Whitman B Schofield; Noah W Palm
Journal:  Sci Rep       Date:  2019-09-19       Impact factor: 4.379

10.  Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.

Authors:  Ulrich Salzer; Chiara Bacchelli; Sylvie Buckridge; Qiang Pan-Hammarström; Stephanie Jennings; Vassilis Lougaris; Astrid Bergbreiter; Tina Hagena; Jennifer Birmelin; Alessandro Plebani; A David B Webster; Hans-Hartmut Peter; Daniel Suez; Helen Chapel; Andrew McLean-Tooke; Gavin P Spickett; Stephanie Anover-Sombke; Hans D Ochs; Simon Urschel; Bernd H Belohradsky; Sanja Ugrinovic; Dinakantha S Kumararatne; Tatiana C Lawrence; Are M Holm; Jose L Franco; Ilka Schulze; Pascal Schneider; E Michael Gertz; Alejandro A Schäffer; Lennart Hammarström; Adrian J Thrasher; H Bobby Gaspar; Bodo Grimbacher
Journal:  Blood       Date:  2008-11-03       Impact factor: 22.113

View more
  2 in total

1.  Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus.

Authors:  Pilar Ortiz-Aljaro; Marco Antonio Montes-Cano; José-Raúl García-Lozano; Virginia Aquino; Rosario Carmona; Javier Perez-Florido; Francisco José García-Hernández; Joaquín Dopazo; María Francisca González-Escribano
Journal:  Sci Rep       Date:  2022-07-02       Impact factor: 4.996

2.  TNFRSF13B genotypes control immune-mediated pathology by regulating the functions of innate B cells.

Authors:  Mayara Garcia de Mattos Barbosa; Adam R Lefferts; Daniel Huynh; Hui Liu; Yu Zhang; Beverly Fu; Jenna Barnes; Milagros Samaniego; Richard J Bram; Raif S Geha; Ariella Shikanov; Eline T Luning Prak; Evan A Farkash; Jeffrey L Platt; Marilia Cascalho
Journal:  JCI Insight       Date:  2021-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.